Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.14 +0.02 (+1.75%)
As of: Oct 23, 2026 · 3:29 PM EDT

Dogwood Therapeutics (DWTX) EBITDA Margin (2025)

Updated

Analysis

Dogwood Therapeutics (DWTX) EBITDA Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 32.68%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 49.01%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.02%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 33.11%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 39.16%
10 Dogwood Therapeutics 38.91 Mn -581,636.07 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,684.09%
Jun 30, 2025 -3,506.82%
API Access

Dogwood Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=DWTX&period=max&api_key=YOUR_API_KEY